ChemCo Tirzepatide 60mg Pen – High-Purity Research Compound

The ChemCo Tirzepatide 60mg Pen delivers a high-concentration, analytical-grade presentation of Tirzepatide (LY3298176) engineered for high-throughput dual-receptor binding assays, extended longitudinal metabolic studies, and comparative incretin signaling kinetics. Containing 60mg of total active dual-acting synthetic peptide, this pre-filled dialable pen format provides maximum operational efficiency, eliminates manual reconstitution steps, and guarantees volumetric consistency across complex, multi-stage laboratory trials.

Technical Specifications & Chemical Profile

• Product Identifier: ChemCo Tirzepatide 60mg Pen

• Active Compound: Tirzepatide (LY3298176)

• Total Concentration: 60mg per pen unit

• Chemical Class: Synthetic Dual GIP / GLP-1 Receptor Agonist

• CAS Registry Number: 2023788-19-2

• Molecular Formula: $C_{225}H_{348}N_{48}O_{68}$

• Molecular Weight: 4813.45 g/mol

• Structural Profile: 39-amino-acid peptide backbone with a $C_{20}$ fatty diacid acylation chain

• Purity Threshold: ≥98% (HPLC & LC-MS Verified)

• Delivery Format: Precision Dialable Multi-Dose Pen Presentation

For mid-range study designs, compare specifications with the ChemCo Tirzepatide 40mg Pen, explore triple-agonist kinetics via the ChemCo Retatrutide 60mg Pen, or view all compounds on the ChemCo Peptides Hub.

Technical Advantages of the Tirzepatide 60mg Pen Presentation

Selecting a high-capacity tirzepatide 60mg pen UK inventory unit provides distinct procedural advantages for research teams managing extended protocols:

1. Extended Long-Arm Study Yield: The 60mg total capacity supplies sufficient active mass for high-frequency sampling and long-term cellular trials without inter-batch variability.

2. Elimination of Reconstitution Overhead: Pre-formulated liquid stabilization removes solvent calculation errors and prevents peptide aggregation during manual dilution.

3. Calibrated Dialing Mechanism: Precision click-wheel interface permits micro-litre adjustment for exact dosage control across variable experimental matrix designs.

Dual Agonist Mechanism of Action & Research Applications

When evaluating chemco tirzepatide 60mg pen samples, researchers examine a dual-target peptide sequence engineered to co-activate glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) signaling cascades:

                          ┌──> GIP Receptor (Adipocyte Dynamics & Glucagon Balance)
                          │
ChemCo Tirzepatide 60mg ──┼──> GLP-1 Receptor (cAMP Signaling & Beta-Cell Secretion)
(LY3298176)               │
                          └──> Synergistic Receptor Co-Action & Metabolic Homeostasis

1. High-Affinity GIP Receptor Activation

Tirzepatide acts as a potent agonist at the GIP receptor, enabling researchers to analyze GIP-driven lipid metabolism, substrate utilization, and glucagon receptor cross-talk.

2. GLP-1 Receptor Signal Transduction

Engages the GLP-1 pathway to promote glucose-dependent insulin secretion and evaluate satiety pathway signaling in cell and tissue culture models.

3. Quantitative Incretin Benchmarking

Provides an ideal high-concentration baseline for comparative studies against selective single-agonists (e.g., Semaglutide) and multi-agonists (e.g., Retatrutide).

Quality Control & Analytical Batch Testing

Every tirzepatide 60mg pen supplied by ChemCo Medical is backed by batch-specific, verifiable analytical documentation:

• High-Performance Liquid Chromatography (HPLC): Confirms sequence purity meets or exceeds 98% and excludes acylation cleavage products.

• Liquid Chromatography-Mass Spectrometry (LC-MS): Verifies structural mass (4813.45 Da) and primary amino acid sequence integrity.

• Endotoxin & Sterility Inspection: Manufactured under strict laboratory controls to guarantee low endotoxin levels suitable for sensitive in vitro assays.

Storage & Handling Guidelines

• Unopened Storage: Maintain under refrigeration at 2°C to 8°C inside original packaging to shield solution from UV degradation.

• In-Use Handling: Return unit to cold storage (2°C–8°C) immediately following sample withdrawal.

• Thermal Notice: Avoid freezing liquid pen cartridges to prevent mechanical ring damage or peptide bond denaturation.

Mandatory Research Compliance Notice

• Strictly for Laboratory and Scientific Research Only: The ChemCo Tirzepatide 60mg Pen is supplied strictly for in vitro laboratory research, analytical testing, and scientific study.

• Not for Human or Veterinary Administration: This product is explicitly prohibited from being used as a drug, human weight-loss product, therapeutic substance, or medical device.